Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1,486.00p

Buy

1,487.00p

arrow-down-2.00p (-0.13%)

Prices updated at 12 Jun 2026, 18:38 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, Rx, and branded. The majority of the company ...
FTSE All-Share
arrow-up1.61%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Mazen Samih Taleb Darwazah
CEO
Mr. Said Darwazah
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
9,603
Head office
10 Portman Square
London
United Kingdom
W1H 6AZ
mobile
+44 2073992760
letter
uk-investors@hikma.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Douglas Michael Hurt
Non-Executive Director, Senior Independent Director
-
Ms. Victoria Mary Hull
Non-Executive Director, Chairman
-
Mr. Mohammed Ali Khaldoun S Al-Husry
Non-Executive Director
-
Ms. Cynthia L. Flowers
Non-Executive Director
-
Dr. Deneen Vojta, M.D.
Non-Executive Director
-
Ms. Laura Balan
Non-Executive Director
-
Mr. Mazen Samih Taleb Darwazah
Executive Director, Vice Chairman
-
Mr. Said Darwazah
Executive Director, Chief Executive Officer
-
Mr. Khalid Walid Hussni Nabilsi
Executive Director
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Boston Partners5,027,950
Jupiter Unit Trust Managers Ltd4,648,633
Jupiter UK Income Fund4,648,633
John Hancock Investment Management LLC4,491,034
JHancock Disciplined Value Intl Fd4,489,801

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
01 Jun 2026Transfer in
01 Jun 2026Transfer in
01 Jun 2026Transfer in
01 Jun 2026Transfer in
01 Jun 2026Transfer in
01 Jun 2026Transfer in
27 Apr 2026Purchase
19 Dec 2025Purchase
07 Nov 2025Purchase
07 Nov 2025Purchase
07 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
06 Nov 2025Purchase
22 Sep 2025D
16 Sep 2025Purchase
22 Aug 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.